Separate names with a comma.
Discussion in 'Dey' started by Anonymous, Aug 25, 2012 at 2:23 PM.
Who is now managing Epipen.....Hope they are geared to take on Auvi
New products are flopping right now. Dr's don't want to mess with them and the MC coverage is not very good. I would be shocked if it takes off.
But I bet they have DVDs before we do. Lmao
If they did their homework and launch into Allergists and PCPs, they will hurt EpiPen. The market has been begging for a smaller, more intutitive device for years yet all EpiPen did was make a bigger device. Oh, I forgot it fits well in your hand and has needle protection - for all those times when you actually do use it - not! Beware - this is not another TwinJect. I look for them to take at least 20-25% by the end of year 1.
20-25% share by the end of the year? This is either a hopeful Sanofi rep or you have been drinking a little too much. You have no idea the cost or manged care coverage.
Seems like Auvi-Q is more successful than initially thought. Judging from the blogosphere and initial reports, a home run for Sanofi.
Well Food Allergies12. I see you have posted both here and on Sanofi page and no one on either page seems to agree with your assessment. Enjoy the kool-aid
Yeah, a home run for patient deaths from a crappy product. Good luck promoting death-q. Go away now.
12 weeks into launch and just now hitting 1% market share. I predict 10% market share at 36 months. Then... Sanofi will pull the plug.
TV spot is casting? That will help.
How do you like the new "jean pocket ad?" Used a back to school marketing genius and stole your 0$ Copay Idea and it works like a gem! I would call it a copay card but the fukin thing was soo big and old school (like your Epi Log) all we did was take the idea and make it cooler and smaller... sound familiar? hope you idiots stretched that extra 500 bucks for allergy week a lot further than last year!
Jean pocket ad? For Auvi-Q? Nobody told us about that (as usual the last to know).
Go on SA or A-Q website for details, seems like they have a strong marketing team! Thoughts on ad and their attempts to own accts?